EULAV Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $2.09M | Sell |
|
|||||
|
2025
Q1 | $7.42M | Sell |
|
|||||
|
2024
Q4 | $7.1M | Sell |
|
|||||
|
2024
Q3 | $9.21M | Buy |
|
|||||
|
2024
Q2 | $9.55M | Sell |
|
|||||
|
2024
Q1 | $10.6M | Sell |
|
|||||
|
2023
Q4 | $12.5M | Sell |
|
|||||
|
2023
Q3 | $11.7M | Buy |
|
|||||
|
2023
Q2 | $8.24M | Buy |
|
|||||
|
2023
Q1 | $8.27M | Buy |
|
|||||
|
2022
Q4 | $8.59M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $10.2M | Sell |
|
|||||
|
2020
Q2 | $19.5M | Sell |
|
|||||
|
2020
Q1 | $14.4M | Sell |
|
|||||
|
2019
Q4 | $16.7M | Sell |
|
|||||
|
2019
Q3 | $13.5M | Sell |
|
|||||
|
2019
Q2 | $17.6M | Buy |
|
|||||
|
2019
Q1 | $8.32M | Sell |
|
|||||
|
2018
Q4 | $8.52M | Sell |
|
|||||
|
2018
Q3 | $10.6M | Sell |
|
|||||
|
2018
Q2 | $11.8M | Buy |
|
|||||
|
2018
Q1 | $8.03M | Sell |
|
|||||
|
2017
Q4 | $9.19M | Sell |
|
|||||
|
2017
Q3 | $9.77M | Buy |
|
|||||
|
2017
Q2 | $8.9M | Buy |
|
|||||
|
2017
Q1 | $7.9M | Sell |
|
|||||
|
2016
Q4 | $7.54M | Sell |
|
|||||
|
2016
Q3 | $8.51M | Buy |
|
|||||
|
2016
Q2 | $5.52M | Hold |
|
|||||
|
2016
Q1 | $5.86M | Buy |
|
|||||
|
2015
Q4 | $4.82M | Sell |
|
|||||
|
2015
Q3 | $6.42M | Buy |
|
|||||
|
2015
Q2 | $2.6M | Buy |
|